Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




What Do Pemetrexed and Cetuximab Offer Patients With NSCLC?What Do Pemetrexed and Cetuximab Offer Pa
Link ID 37584
Title What Do Pemetrexed and Cetuximab Offer Patients With NSCLC?What Do Pemetrexed and Cetuximab Offer Pa
Url http://www.medscape.com/viewarticle/749450?src=rsshttp://www.medscape.com/viewarticle/749450?src=rss
Description Within the limited landscape of effective chemotherapeutic agents for non-small cell lung cancer, do these new agents deserve further study? Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Sep 15, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. SABCS: Focus on Adjuvant and Neoadjuvant Therapy
  Dr. Kathy Miller gives an overview of key studies to be presented at SABCS, which this year highlight breast cancer therapy in the adjuvant and neoadjuvant settings. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. Breast Cancer Gene-Expression Assays Show Promise but More Data Are Needed
  Gene-expression profiling assays in early-stage breast cancer have shown potential in improving predictions of prognosis and treatment benefit, but more information is needed about how they are best incorporated into decision making about current breast cancer treatment. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Stopping Hospice Care Raises Healthcare Costs for Cancer Patients
  The cost of care is significantly higher for cancer patients who disenroll from hospice care, because they are far more likely to seek emergency services and/or be hospitalized. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Reproductive Factors May Be Linked to Risk for Certain Breast Cancers
  A study shows that factors such as age at menopause and breast-feeding practices may influence the risk for the development of certain types of breast cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. First Drug for Myelofibrosis Offers Symptom Relief
  The drug ruxolitinib significantly reduced the size of the spleen in patients with myeloproliferative disorder, the major symptom of which is an enlarged spleen. br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS